Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 595-605

  Augustin, Danielle K ^a   Heimer, Susan R ^b,d   Tam, Connie ^b   Li, Wing Y ^b   Le Due, Jeff M ^b   Evans, David J ^b,d   Fleiszig, Suzanne M J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BETA DEFENSIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA PERFORATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SUPERNATANT;

ANIMALS; BETA-DEFENSINS; CELL LINE; DEFENSINS; EPITHELIUM, CORNEAL; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PSEUDOMONAS AERUGINOSA;

EID: 79251524878     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00854-10     Document Type: Article

References (58)

1. Alarcon, I., D. J. Evans, and S. M. Fleiszig. 2009. The role of twitching motility in Pseudomonas aeruginosa exit from and translocation of corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 50:2237-2244.
2. Alarcon, I., L. Kwan, C. Yu, D. J. Evans, and S. M. Fleiszig. 2009. Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa. Infect. Immun. 77:3264-3271.
3. Alarcon, I., et al. Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Invest. Ophthalmol. Vis. Sci., in press.
4. Azghani, A. O. 1996. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. Am. J. Respir. Cell Mol. Biol. 15:132-140.
5. Azghani, A. O., L. D. Gray, and A. R. Johnson. 1993. A bacterial protease perturbs the paracellular barrier function of transporting epithelial monolayers in culture. Infect. Immun. 61:2681-2686.
6. Bals, R., et al. 1999. Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect. Immun. 67:3542-3547.
7. Barton, G. M., and R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science 300:1524-1525.
8. Chen, X., et al. 2005. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 40:123-132. (Pubitemid 41446209)
9. Evans, D. J., N. A. McNamara, and S. M. Fleiszig. 2007. Life at the front: dissecting bacterial-host interactions at the ocular surface. Ocul. Surf. 5:213-227.
10. Fleiszig, S. M., et al. 1997. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect. Immun. 65:2861-2867.
11. Fleiszig, S. M., et al. 1998. Susceptibility of epithelial cells to Pseudomonas aeruginosa invasion and cytotoxicity is upregulated by hepatocyte growth factor. Infect. Immun. 66:3443-3446.
12. Fleiszig, S. M., et al. 1997. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect. Immun. 65:579-586.
13. Fleiszig, S. M., T. S. Zaidi, R. Ramphal, and G. B. Pier. 1994. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus. Infect. Immun. 62:1799-1804.
14. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710-720.
15. Gao, N., A. Kumar, J. Jyot, and F. S. Yu. Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway. PLoS One 5:e9351.
16. Gipson, I. K., and P. Argueso. 2003. Role of mucins in the function of the corneal and conjunctival epithelia. Int. Rev. Cytol. 231:1-49.
17. Hauber, H. P., et al. 2007. LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J. Endotoxin Res. 13:109-116.
18. Hazlett, L. D. 2004. Corneal response to Pseudomonas aeruginosa infection. Prog. Retin. Eye Res. 23:1-30.
19. Hirakata, Y., et al. 2000. Penetration of clinical isolates of Pseudomonas aeruginosa through MDCK epithelial cell monolayers. J. Infect. Dis. 181:765-769.
20. Hirakata, Y., et al. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.
21. Huang, L. C., D. Jean, R. J. Proske, R. Y. Reins, and A. M. McDermott. 2007. Ocular surface expression and in vitro activity of antimicrobial peptides. Curr. Eye Res. 32:595-609.
22. Huang, L. C., R. L. Redfern, S. Narayanan, R. Y. Reins, and A. M. McDermott. 2007. In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid. Antimicrob. Agents Chemother. 51:3853-3860.
23. Huang, L. C., R. Y. Reins, R. L. Gallo, and A. M. McDermott. 2007. Cathelicidin-deficient (Cnlp-/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 48:4498-4508.
24. Ibrahim, Y. W., D. L. Boase, and I. A. Cree. 2009. Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br. J. Ophthalmol. 93:1319-1324.
25. Kazmierczak, B. I., K. Mostov, and J. N. Engel. 2001. Interaction of bacterial pathogens with polarized epithelium. Annu. Rev. Microbiol. 55:407-435.
26. Kierbel, A., et al. 2007. Pseudomonas aeruginosa exploits a PIP3-dependent pathway to transform apical into basolateral membrane. J. Cell Biol. 177:21-27.
27. Kumar, A., N. Gao, T. J. Standiford, R. L. Gallo, and F. S. Yu. 2010. Topical flagellin protects the injured corneas from Pseudomonas aeruginosa infection. Microbes Infect. 12:978-989.
28. Kuroki, Y., M. Takahashi, and C. Nishitani. 2007. Pulmonary collectins in innate immunity of the lung. Cell. Microbiol. 9:1871-1879.
29. Kwong, M. S., D. J. Evans, M. Ni, B. A. Cowell, and S. M. Fleiszig. 2007. Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model. Infect. Immun. 75:2325-2332.
30. Laube, D. M., S. Yim, L. K. Ryan, K. O. Kisich, and G. Diamond. 2006. Antimicrobial peptides in the airway. Curr. Top. Microbiol. Immunol. 306:153-182.
31. Lee, E. J., B. A. Cowell, D. J. Evans, and S. M. Fleiszig. 2003. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest. Ophthalmol. Vis. Sci. 44:3892-3898.
32. Lee, E. J., D. J. Evans, and S. M. Fleiszig. 2003. Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model. Invest. Ophthalmol. Vis. Sci. 44:5220-5227.
33. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
34. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2:1051-1060.
35. Maltseva, I. A., et al. 2007. Exposure of human corneal epithelial cells to contact lenses in vitro suppresses the upregulation of human beta-defensin-2 in response to antigens of Pseudomonas aeruginosa. Exp. Eye Res. 85:142-153.
36. Masinick, S. A., C. P. Montgomery, P. C. Montgomery, and L. D. Hazlett. 1997. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis. Invest. Ophthalmol. Vis. Sci. 38:910-918.
37. McDermott, A. M. 2009. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 41:60-75.
38. McDermott, A. M., et al. 2003. Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 44:1859-1865.
39. McNamara, N., and C. Basbaum. 2001. Signaling networks controlling mucin production in response to Gram-positive and Gram-negative bacteria. Glycoconj. J. 18:715-722.
40. McNamara, N. A., R. Van, O. S. Tuchin, and S. M. Fleiszig. 1999. Ocular surface epithelia express mRNA for human beta defensin-2. Exp. Eye Res. 69:483-490.
41. Mendez-Samperio, P., E. Miranda, and A. Trejo. 2008. Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis bacillus Calmette-Guerin. Clin. Vaccine Immunol. 15:1450-1455.
42. Menendez, A., and B. B. Finlay. 2007. Defensins in the immunology of bacterial infections. Curr. Opin. Immunol. 19:385-391.
43. Mun, J. J., et al. 2009. Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect. Immun. 77:2392-2398.
44. Nagaoka, I., S. Hirota, S. Yomogida, A. Ohwada, and M. Hirata. 2000. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49:73-79.
45. Ni, M., et al. 2005. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect. Immun. 73:2147-2156.
46. Ni, M., et al. 2008. Expression of surfactant protein D in human corneal epithelial cells is upregulated by Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 54:177-184.
47. Paris, S., M. Wolgin, A. M. Kielbassa, A. Pries, and A. Zakrzewicz. 2009. Gene expression of human beta-defensins in healthy and inflamed human dental pulps. J. Endod. 35:520-523.
48. Pearlman, E., et al. 2008. Toll-like receptors at the ocular surface. Ocul. Surf. 6:108-116.
49. Priebe, G. P., G. J. Meluleni, F. T. Coleman, J. B. Goldberg, and G. B. Pier. 2003. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infect. Immun. 71:1453-1461.
50. Robertson, D. M., et al. 2005. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest. Ophthalmol. Vis. Sci. 46:470-478.
51. Soong, G., D. Parker, M. Magargee, and A. S. Prince. 2008. The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J. Bacteriol. 190:2814-2821.
52. Sosnova-Netukova, M., P. Kuchynka, and J. V. Forrester. 2007. The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes. Br. J. Ophthalmol. 91:372-378.
53. Stapleton, F., et al. 2008. The incidence of contact lens-related microbial keratitis in Australia. Ophthalmology 115:1655-1662.
54. Tam, C., J. J. Mun, D. J. Evans, and S. M. J. Fleiszig. 2010. The impact of inoculation parameters on the pathogenesis of contact lens-related infectious keratitis. Invest. Ophthalmol. Vis. Sci. 51:3100-3106.
55. Wu, H., et al. 2003. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J. Clin. Invest. 111:1589-1602.
56. Wu, M., S. A. McClellan, R. P. Barrett, Y. Zhang, and L. D. Hazlett. 2009. Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J. Immunol. 183:8054-8060.
57. Yu, F. S., et al. Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. J. Immunol. 185:1142-1149.
58. Zulianello, L., et al. 2006. Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect. Immun. 74:3134-3147. (Pubitemid 43794502)